Ionis Pharmaceuticals, Inc.
METHODS FOR REDUCING ATAXIN-2 EXPRESSION

Last updated:

Abstract:

Provided herein are methods for decreasing Ataxin-2 mRNA expression. Such methods are useful to ameliorate symptoms of Ataxin-2 associated diseases. Such Ataxin-2 associated diseases include amyotrophic lateral sclerosis (ALS). Such symptoms include loss of motor function, reduced CMAP amplitude, denervation, and loss of motor neurons.

Status:
Application
Type:

Utility

Filling date:

18 May 2021

Issue date:

26 May 2022